Jul 1, 2025, 08:19 AM by

Oxford-based Ochre Bio, a biotechnology company developing RNA therapeutics for chronic liver disease, has appointed Dr Quin Wills as CEO.

Jul 1, 2025, 08:19 AM by

PharmaForceIQ has announced a period of significant growth as it goes beyond omnichannel to optichannel campaign solutions. The company is the fastest growing independent provider of precision customer engagement technologies for the Life Science industry, and it has experienced a multifold increase in average contract value in the past year. In one client, the company expanded from a pilot campaign for one specialty brand to their entire specialty pharmaceutical portfolio in only 7 months. PharmaForceIQ also has a 100% client renewal rate – demonstrating that its data-driven strategies deliver unmatched efficiency and tangible results

Jul 1, 2025, 08:19 AM by

Jul 1, 2025, 01:00 AM by User Not Found

Bio-IT World | In Stanford University's engineering labs, Tom Soh has been wrestling with a paradox that has plagued medicine for decades. While modern jet engines generate terabytes of data every hour to prevent catastrophic failures, the human body gets monitored only during annual checkups or after something has already gone wrong.

Jun 30, 2025, 08:12 AM by

Laverock Therapeutics closes additional seed funding round, bringing total raised to more than £20m, and announces key data

Jun 30, 2025, 08:12 AM by

Rewriting the Timeline of Detection: Linus Health's Digital Platform Uncovers the Earliest Signs of Cognitive Decline

Jun 27, 2025, 08:17 AM by

Baylor Genetics, a leading clinical diagnostic laboratory at the forefront of genetic testing, today announced its support for the American Academy of Pediatrics’ (AAP) updated guidance recommending whole genome and whole exome sequencing as first-tier tests. Baylor Genetics has long recognized the value of these tests, and offers a comprehensive, structured framework to help pediatricians promptly identify potential genetic causes in children presenting with global developmental delay (GDD) or intellectual disability (ID). This milestone empowers pediatricians, supported by genetics professionals, with access to earlier and more comprehensive insights that guide clinical decisions for patients and their families, marking a critical step toward faster diagnoses and improved outcomes.

Jun 26, 2025, 07:59 AM by

The project aims at translational mechanistic modeling of antibodies to predict human pharmacokinetics and target occupancy in cerebrospinal fluid

Jun 26, 2025, 07:59 AM by

Alithea Genomics has announced the commercial launch of MERCURIUS™ FLASH-seq, a next-generation library preparation kit for full-length single-cell RNA sequencing.

Jun 26, 2025, 07:59 AM by

ISM3412 was designed with the support of Chemistry42, Insilico’s proprietary generative chemistry engine, for the treatment of locally advanced and metastatic solid tumors. The Phase I study of ISM3412 is currently recruiting in multiple sites across the United States and China, aiming to evaluate the safety, tolerability, PK/PD profiles and preliminary efficacy in patients.

Jun 26, 2025, 01:00 AM by User Not Found

Bio-IT World | The UK's National Health Service is pioneering a new approach to precision medicine through pharmacogenomic testing that could transform how doctors prescribe medications and significantly reduce healthcare costs. Early results from the NHS PROGRESS trial suggest that genetic testing can guide prescribing decisions for nearly all patients, with one in four participants having their prescriptions adjusted for safer or more effective treatment.

Jun 25, 2025, 08:26 AM by

Jun 25, 2025, 08:26 AM by

Jun 25, 2025, 08:26 AM by

AMP recently published a new report with 12 best practice recommendations focused on the design and validation of clinical HRD assays. To develop these recommendations, AMP assembled an expert panel that included organizational representation from ACCC, ASCO, and the CAP.

Jun 25, 2025, 08:26 AM by

Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), today announced the appointment of Billy Amzal as Head of Strategic Consulting.

Jun 25, 2025, 08:26 AM by

Avalon 2025 Lab Trend Report: Genetic Testing Soars as Routine Testing Stabilizes

Jun 25, 2025, 08:26 AM by

To make it easier for researchers to find and access the specialized chemicals they need, Alfa Chemistry has announced that it has been added as a supplier to the CHEMnetBASE dictionaries, the world’s premier collection of interactive chemistry databases from CRC Press, Taylor & Francis Group. This means that Alfa Chemistry’s vast catalog of specialized chemicals will be easily discoverable within the premier digital chemistry resource used by researchers and scientists around the world.

Jun 25, 2025, 01:00 AM by User Not Found

Bio-IT World | ITM plans to use their financing to prepare for commercial readiness and potential market launch of the company’s lead candidate, n.c.a. 177Lu-edotreotide, which treats gastroenteropancreatic neuroendocrine tumors; GRIN and Angelini Pharma will develop and expand commercial rights outside of North America for GRIN's investigational drug radiprodil, which treats rare genetic epilepsies and neurodevelopmental disorders; and more.

Jun 24, 2025, 08:19 AM by

Vaxess Technologies, Inc., a biotech company developing a novel microarray patch technology to transform home delivery of therapies, is presenting new preclinical data at the 2025 American Diabetes Association (ADA) Scientific Sessions in Chicago.

Jun 24, 2025, 01:00 AM by User Not Found

Bio-IT World | Pangaea Data has entered into a collaboration agreement with Alexion to develop an Artificial Intelligence Clinical Decision Support System; Dell Technologies will develop NERSC-10, the next flagship supercomputer at the National Energy Research Scientific Computing Center; and more.